CO6400174A2 - Composición que comprende ácido chicórico y/o derivados del mismo - Google Patents

Composición que comprende ácido chicórico y/o derivados del mismo

Info

Publication number
CO6400174A2
CO6400174A2 CO11087834A CO11087834A CO6400174A2 CO 6400174 A2 CO6400174 A2 CO 6400174A2 CO 11087834 A CO11087834 A CO 11087834A CO 11087834 A CO11087834 A CO 11087834A CO 6400174 A2 CO6400174 A2 CO 6400174A2
Authority
CO
Colombia
Prior art keywords
acid
derivatives
composition
chicoric acid
chicoric
Prior art date
Application number
CO11087834A
Other languages
English (en)
Inventor
Rachid Bel-Rhlid
Vanessa Crespy
Thomas Wolfgang Raab
Nicole Page-Zoerkler
Rene Fumeaux
Maricel Marin-Kuan
Dominique Piguet
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CO6400174A2 publication Critical patent/CO6400174A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42—Hydroxy-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/44—Polycarboxylic acids
    • C12P7/46—Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/0102—Tannase (3.1.1.20)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/151—Johnsonii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Botany (AREA)

Abstract

La presente invención se refiere de manerageneral al campo de alimentos y bebidas, En particular, porejemplo, se proporciona una composición que permitesuministrar ácido tartárico y/o ácido caféico a un sujeto.Una modalidad de la presente invención es unacomposición que comprende un ingrediente que contieneácido chicórico y/o derivados del mismo, y una bacteria deácido láctico capaz de hidrolizar ácido chicórico y/oderivados del mismo para generar ácido tartárico y/ocaféico.
CO11087834A 2009-01-27 2011-07-13 Composición que comprende ácido chicórico y/o derivados del mismo CO6400174A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09151390A EP2210504A1 (en) 2009-01-27 2009-01-27 Composition comprising chicoric acid and/or derivatives thereof

Publications (1)

Publication Number Publication Date
CO6400174A2 true CO6400174A2 (es) 2012-03-15

Family

ID=40635768

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11087834A CO6400174A2 (es) 2009-01-27 2011-07-13 Composición que comprende ácido chicórico y/o derivados del mismo

Country Status (14)

Country Link
US (1) US20110280848A1 (es)
EP (2) EP2210504A1 (es)
JP (1) JP2012515541A (es)
KR (1) KR20110119723A (es)
CN (1) CN102333455A (es)
AR (1) AR075188A1 (es)
AU (1) AU2010209797A1 (es)
BR (1) BRPI1007194A2 (es)
CA (1) CA2750685A1 (es)
CO (1) CO6400174A2 (es)
MX (1) MX2011007471A (es)
RU (1) RU2011135819A (es)
WO (1) WO2010086322A1 (es)
ZA (1) ZA201106300B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1917960A1 (en) * 2006-11-06 2008-05-07 Nestec S.A. Improved biological effects of rosmarinic acid
EP2588071B1 (en) * 2010-06-30 2019-05-22 Nestec S.A. Use of chicoric acid and derivatives for lightening and/or whitening skin tone
ES2744576T3 (es) 2010-06-30 2020-02-25 Nestle Sa Uso de ácido cicórico y bacteria láctica en suplemento alimenticio para aclarar y/o blanquear el tono de la piel
JP2013530996A (ja) * 2010-06-30 2013-08-01 ネステク ソシエテ アノニム 皮膚の色素沈着を調節するための、栄養補助食品におけるカフタル酸及び誘導体の使用
US20140242010A1 (en) * 2011-10-11 2014-08-28 Elc Management Llc Method And Compositions For Treating Skin
WO2013190068A1 (en) 2012-06-22 2013-12-27 Nestec S.A. Probiotic and polyphenol against neurodegeneration
CN105392491A (zh) * 2013-03-12 2016-03-09 Hmi医疗创新有限公司 具有抗糖尿病和其它有用活性的植物提取物
CN103408423A (zh) * 2013-07-17 2013-11-27 张家港威胜生物医药有限公司 一种天然活性产物l-菊苣酸的合成工艺
KR20170032815A (ko) * 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
WO2019181783A1 (ja) * 2018-03-23 2019-09-26 森永乳業株式会社 臭い成分不活性化用組成物
CN110786241B (zh) * 2019-11-28 2022-03-22 大连市现代农业生产发展服务中心(大连市农业科学研究院) 一种提高液体培养紫锥菊不定根中菊苣酸积累的培养方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU459273B2 (en) * 1971-05-17 1975-03-20 Sankyo Company Limited Process for making wines
FR2591073B1 (fr) * 1985-12-10 1988-02-19 Leroux Sarl Chicoree Boisson a base de chicoree et procede de preparation de ladite boisson
JP2003250528A (ja) * 2002-03-06 2003-09-09 Yakult Honsha Co Ltd ビフィドバクテリウム属細菌の生残性改善剤、増殖促進剤、又は、同細菌含有醗酵物の製造方法
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
EP1610623B1 (en) * 2003-03-25 2011-11-23 Aarhus Universitet Methodologies for improving the quality of meat, health status of animals and impact on environment
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
AU2005279724B2 (en) * 2004-09-01 2010-03-25 Pioneer Hi-Bred International, Inc. Ferulate esterase producing strains and methods of using same
RU2427382C2 (ru) * 2005-09-28 2011-08-27 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Способ снижения артериального давления у индивидов с состоянием, предшествующим гипертензии, и/или у индивидов с метаболическим синдромом
PL1937091T3 (pl) * 2005-09-28 2015-11-30 Constellation Brands Inc Ekstrakt z winogron, jego suplement diety i jego przetwarzanie
FR2904935A1 (fr) * 2006-08-18 2008-02-22 Centre Nat Rech Scient Composition antidiabetique apte a stimuler la secretion d'insuline et destinee au traitement du diabete de type 2 (diabete non insulino-dependant).
WO2008028300A1 (en) * 2006-09-07 2008-03-13 Mcgill University Oral polymeric membrane feruloyl esterase producing bacteria formulation
EP1917960A1 (en) * 2006-11-06 2008-05-07 Nestec S.A. Improved biological effects of rosmarinic acid
EP1932517A3 (en) * 2006-12-11 2008-07-16 Universiteit Utrecht Holding B.V. Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof
JP4990297B2 (ja) * 2007-02-01 2012-08-01 株式会社Ｔｋバイオ研究所 ブドウ果皮・種子乳酸菌発酵物及びそれを利用した医薬
EP1985191A1 (en) * 2007-04-27 2008-10-29 Universita'degli Studi Di Milano Preparation of polyfunctional fermented food products
MX2010011059A (es) * 2008-04-30 2010-11-12 Nestec Sa Composiciones para preparar una bebida de cafe que comprende acido clorogenico hidrolizado.
WO2009155689A1 (en) * 2008-06-24 2009-12-30 Micropharma Limited Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections

Also Published As

Publication number Publication date
CN102333455A (zh) 2012-01-25
BRPI1007194A2 (pt) 2015-08-25
RU2011135819A (ru) 2013-03-10
CA2750685A1 (en) 2010-08-05
US20110280848A1 (en) 2011-11-17
KR20110119723A (ko) 2011-11-02
AR075188A1 (es) 2011-03-16
WO2010086322A1 (en) 2010-08-05
AU2010209797A1 (en) 2011-07-28
EP2210504A1 (en) 2010-07-28
MX2011007471A (es) 2011-08-03
EP2391228A1 (en) 2011-12-07
JP2012515541A (ja) 2012-07-12
ZA201106300B (en) 2013-02-27

Similar Documents

Publication Publication Date Title
CO6400174A2 (es) Composición que comprende ácido chicórico y/o derivados del mismo
CO6390087A2 (es) Composición que comprende ácido caftárico y/o derivados del mismo
AR085943A1 (es) Composicion antimicrobiana
MX2013011430A (es) Bebida proteica y método para su preparación.
BR112015028385A2 (pt) composição compreendendo bactérias de ácido láctico para uso no tratamento preventivo e/ou curativo da vaginose bacteriana
IN2015DN01198A (es)
CL2011002818A1 (es) Composicion de leche para el crecimiento que comprende microorganismos probioticos; uso de dicha composicion para preparar medicamento util para prevenir o tratar trastornos inflamatorios.
BR112012033212A2 (pt) uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica
MX2015017994A (es) Metodos de conservacion biologica para bebidas y otros alimentos.
BR112012018882A2 (pt) "bactéria láctica para produtos alimentícios texturizados selecionados com base em fago resistência"
BR112012004706A2 (pt) bactéria lática com expressão modificada de galacto cinase para texturização de produtos alimentícios através de superexpressão de exopolissacarídeo.
WO2012112777A3 (en) Biosynthesis of human milk oligosaccharides in engineered bacteria
AR071426A1 (es) Extracto de cafe
BR112015027536A8 (pt) composição compreendendo bactérias ácidas lácticas para utilização no tratamento preventivo e/ou curativo de cistite recorrente.
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
MX2011005527A (es) Uso de la bacteria de acido lactico para tratar o prevenir el eczema.
CL2014001239A1 (es) Método para mejorar eficiencia del alimento o de reducir patógenos en un ave que comprende la administración al ave de un suplemento de bacterias del ácido láctico del género lactobacillus ; y composición que comprende las bacterias.
MX2014001329A (es) Uso de bacterias de acido lactico para reducir patogenos y como un biodesinfectante.
IN2012DN02283A (es)
MX2014004710A (es) Composiciones farmaceuticas que comprenden dgla y/o 15-hetre y metodos para usar los mismos.
CL2012002781A1 (es) Producto que comprende un cuerpo de alimento compuesto por un componente de alimento y un componente de infusion que contiene mal todextrina en una concentracon de 5 a 65% con respecto al cuerpo del alimento; producto alimenticio; metodo para producir un cuerpo de alimento infusionado; y formulaciones de infusion.
MX2012007970A (es) Proceso para la preparacion de una biomasa que comprende plantaricina y usos de la misma en el campo medico.
EP2588070B8 (en) USE OF CHICORIC ACID AND LACTIC BACTERIUM IN FOOD SUPPLEMENT FOR lightening and/or whitening skin tone
AR078388A1 (es) Producto lacteo pasteurizado y fermentado, y procedimiento para su preparacion
CL2012003622A1 (es) Uso estetico de acido caftarico y bacteria lactica y/o una enzima capaz de hidrolizar ácido caftárico para generar ácido tartárico y/o caféico para preparar un complemento alimenticio para regular la pigmentacion de la piel; método de tratamiento estético que se usa para tratar y/o prevenir trastornos de la pigmentacion de la piel y/o imperfecciones de la piel; kit para preparar complemento alimenticio.

Legal Events

Date Code Title Description
FG Application granted